Farallon Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,294,115
Closed -$55.9M 93
2015
Q3
$55.9M Buy
+1,294,115
New +$55.9M 0.74% 34